Anthony J Choi1, Preston Atteberry1, Dana J Lukin2,3. 1. Division of Gastroenterology and Hepatology, New York Presbyterian Hospital-Weill Cornell Medical College, New York, USA. 2. Division of Gastroenterology and Hepatology, New York Presbyterian Hospital-Weill Cornell Medical College, New York, USA. djl9010@med.cornell.edu. 3. Jill Roberts Center for IBD, New York Presbyterian Hospital-Weill Cornell Medical College, 1315 York Avenue Mezzinine SM1A15, New York, NY, 10021, USA. djl9010@med.cornell.edu.
Abstract
PURPOSE OF REVIEW: Significant gaps in knowledge and utilization of vaccinations exist among practitioners providing care for patients with IBD. This review is intended to update the reader on best practices for vaccination within the IBD population with a specific focus on the elderly. RECENT FINDINGS: Advances in IBD therapeutics have recently increased the number of immunosuppressive therapies available to practitioners. Differences in mechanisms of action of these medications have led to differential implications pertaining to vaccination strategies. Additionally, new vaccines, including the recombinant zoster vaccine, have recently become available for the use in the IBD population. Given the prominent role the IBD provider plays in the management of patients with IBD, a clear understanding of best practices is essential. This review provides a framework for the integration of optimal vaccination strategies for practitioners caring for adult and elderly patients with IBD.
PURPOSE OF REVIEW: Significant gaps in knowledge and utilization of vaccinations exist among practitioners providing care for patients with IBD. This review is intended to update the reader on best practices for vaccination within the IBD population with a specific focus on the elderly. RECENT FINDINGS: Advances in IBD therapeutics have recently increased the number of immunosuppressive therapies available to practitioners. Differences in mechanisms of action of these medications have led to differential implications pertaining to vaccination strategies. Additionally, new vaccines, including the recombinant zoster vaccine, have recently become available for the use in the IBD population. Given the prominent role the IBD provider plays in the management of patients with IBD, a clear understanding of best practices is essential. This review provides a framework for the integration of optimal vaccination strategies for practitioners caring for adult and elderly patients with IBD.
Authors: Jean-François Rahier; Pavol Papay; Julia Salleron; Shaji Sebastian; Manuela Marzo; Laurent Peyrin-Biroulet; Valle Garcia-Sanchez; Walter Fries; Dirk P van Asseldonk; Klaudia Farkas; Nanne K de Boer; Taina Sipponen; Pierre Ellul; Edouard Louis; Simon T C Peake; Uri Kopylov; Jochen Maul; Badira Makhoul; Gionata Fiorino; Yazdan Yazdanpanah; Maria Chaparro Journal: Gut Date: 2011-01-26 Impact factor: 23.059
Authors: H J Nielsen; T Mortensen; M Holten-Andersen; N Brünner; S Sørensen; J Rask-Madsen Journal: Scand J Gastroenterol Date: 2001-03 Impact factor: 2.423
Authors: Dawn B Beaulieu; Ashwin N Ananthakrishnan; Christopher Martin; Russell D Cohen; Sunanda V Kane; Uma Mahadevan Journal: Clin Gastroenterol Hepatol Date: 2017-09-01 Impact factor: 11.382
Authors: William J Sandborn; Julián Panés; Geert R D'Haens; Bruce E Sands; Chinyu Su; Michele Moscariello; Thomas Jones; Ron Pedersen; Gary S Friedman; Nervin Lawendy; Gary Chan Journal: Clin Gastroenterol Hepatol Date: 2018-11-23 Impact factor: 11.382
Authors: Noa Krugliak Cleveland; Dylan Rodriquez; Alana Wichman; Isabella Pan; Gil Y Melmed; David T Rubin Journal: Dig Dis Sci Date: 2016-08-24 Impact factor: 3.199
Authors: Jason S Reich; Hannah L Miller; Sharmeel K Wasan; Ansu Noronha; Eileen Ardagna; Kathleen Sullivan; Brian Jacobson; Francis A Farraye Journal: Gastroenterol Hepatol (N Y) Date: 2015-06